Ogestan

Ogestan is available in soft capsules, packaged in boxes of 30 units, intended for daily oral administration. The soft capsule makes it easier to swallow and protects sensitive ingredients, such as polyunsaturated fatty acids, from premature oxidation.

Ogestan is also available in sachets, each containing inositol, chromium, green tea extract and folic acid.

Ogestan is indicated for:

• the pre-conception period, to optimise the mother’s reserves of folate and DHA;
• during pregnancy, to support normal foetal brain development and maternal tissue growth;
• breastfeeding, to ensure an adequate supply of DHA necessary for the newborn’s neurological development;
• situations where dietary intake of oily fish or iodine is insufficient.

Taking Ogestan during pregnancy or breastfeeding contributes to the normal brain development of the foetus and breastfed infants, with beneficial effects achieved through a daily supplement of 200 mg of DHA in addition to the usual recommended dose for adults (250 mg of DHA + EPA).

The recommended daily dose is one capsule per day, to be taken before the main meal with a glass of water.

It is recommended to start treatment with Ogestan before pregnancy and to continue it throughout pregnancy and breastfeeding, in order to maintain optimal nutritional status. 

Ogestan is not recommended for women with thyroid disorders, particularly hyperthyroidism or other conditions where additional iodine intake could worsen the clinical picture.

The product contains soya and fish-derived ingredients and is contraindicated for people allergic to these components. Caution and medical advice are recommended in cases of coagulation disorders.

As a food supplement, Ogestan should not replace a varied and balanced diet, but rather supplement nutritional intake in specific situations.

Taking it during the pre-conception period is essential, as the closure of the foetal neural tube occurs in the first weeks of pregnancy, often before pregnancy is confirmed.

Taking Ogestan during pregnancy or before pregnancy is generally well tolerated. Minor digestive reactions, such as mild nausea, abdominal discomfort or reflux with a distinct fishy taste, may rarely occur.

Allergic reactions are possible in people with hypersensitivity to soya, fish or any of the excipients. In the event of skin rashes, itching or other symptoms indicative of an allergy, use should be discontinued and a doctor consulted.

No significant drug interactions are known, but caution is advised when taken concomitantly with other supplements containing folic acid or iodine, or with anticoagulant medicines.

Women undergoing treatment for thyroid disorders should consult their doctor before use. Taking this product alongside high-fat foods may promote optimal absorption of DHA.

Accidental overdose is unlikely if the recommended dose is followed. However, taking excessive amounts of folate or iodine may cause metabolic imbalances or thyroid dysfunction.

In the event of accidental ingestion of a large number of capsules, it is recommended to consult a doctor to assess clinical and biochemical status.

The product should be stored in its original packaging, at temperatures below 25 °C, protected from moisture and direct light.

Keep out of the reach and sight of children. Check the integrity of the capsules before use.

• PubMed, Omega-3 fatty acids and pregnancy
• MDPI, Omega-3 supplementation during pregnancy and risk of preterm birth: a systematic review and meta-analysis
• MDPI, The biological role of folic acid in pregnancy and its potential therapeutic application in the prevention of pre-eclampsia
• JAMA, Folic acid supplementation for the prevention of neural tube defects